Screened 2026-09-11 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its distribution label.
Materion Corporation holds its Distribution at $257.51. Consolidating, no directional conviction, held for 28 days.
As held on the ledger · 2026-09-11
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 28 days
Price at the screen
$257.51
Valuation
60.17 trailing · 30.53 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.08
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
29.55%
Below 33%
Interest-bearing debt is just 29.6% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
13.12%
Below 49%
Money owed to the company is 13.1% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. The price runs 26.7% above the base estimate.
Third-party analyst targets: 5 covering, consensus Buy. The average target sits +19% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Engineered materials look pricey when cycles turn
Every time a plane gets built or a chip line ramps, someone needs specialty alloys and beryllium parts. Materion supplies them, yet the shares trade at 32 times forward earnings while our fair value sits 41 percent lower. Revenue has jumped 31 percent, but margins remain stuck at 4 percent and return on equity at just 8 percent, numbers that rarely survive a downturn in metals demand.
This is a classic cyclical setup dressed up as growth. The low profit margins and modest returns already signal limited pricing power, and paying a premium multiple simply amplifies the risk that peak-cycle earnings will not last. Three analysts may still say buy, yet the gap to their own median target of 225 dollars shows the market is already stretching.
Ethical screens clear the company, yet valuation and industry cyclicality do not. Peak earnings at elevated multiples have trapped investors before; nothing here suggests this time is different. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
MTRN trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 10.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 58% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 175%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $211.
2026-08-06Markup$210.84-14.7%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 14.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 58% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 175%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $211.
2026-07-18Markup$247.26+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 58% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 175%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $211.
2026-07-03Markup$247.26+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$247.26Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
